Search
Search Results
##search.searchResults.foundPlural##
-
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2169PDF: 1586HTML: 265 -
HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ
1037PDF: 926Suppl. Files: 594HTML: 83 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1621PDF: 796HTML: 860jdoe, table 2 infections CML .doc: 194jdoe, table 1 infections CML .doc: 181 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2496PDF: 838HTML: 8820Efremov 1: 226Efremov 2: 189 -
OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT
1301HTML: 307PDF: 933Suppl. Files: 446 -
TIMING FOR STEP-DOWN THERAPY OF CANDIDEMIA IN NON-NEUTROPENIC PATIENTS: AN INTERNATIONAL MULTI-CENTER STUDY Stepdown Therapy of Candidemia
2066PDF: 648HTML: 264 -
HEPARIN-BINDING PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INFECTIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS Heparin-binding protein in adult patients
2201PDF: 991HTML: 147Suppl. Files: 512 -
-
ON THE VERSATILITY OF VON WILLEBRAND FACTOR
2793PDF: 1116HTML: 11216 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2200PDF: 1488HTML: 266 -
-
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2271PDF: 933HTML: 302 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3771PDF: 1483HTML: 485Figures . Eliassian: 222 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
3920Suppl. Files: 1115PDF: 1066Html: 176 -
BACTERIAL INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
3137PDF: 1827HTML: 3569 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1243PDF: 473HTML: 18570Figure 1: 169Figure 2: 150Figure 3: 167Figure 4: 205Figure 5: 176 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2127PDF: 1693HTML: 378 -
POST-TRANSPLANT RELAPSE IN ACUTE LEUKEMIA: COMPARATIVE VALUE OF MRD AND CHIMERISM.
712PDF: 410Suppl. Files: 120HTML: 112 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3325PDF: 1470HTML: 4000 -
ASSESSMENT OF DIAGNOSTIC TECHNIQUES OF URINARY TUBERCULOSIS
2008PDF: 779HTML: 2325Untitled: 210 -
ADVANCES IN THE TREATMENT OF MALARIA
2843PDF: 1123HTML: 5992 -
Massive pulmonary embolism at the onset of acute promyelocytic leukemia
3510PDF: 883HTML: 1653figure 1: 165Untitled: 188







